/

Investors / Belgium / Gemma Frisius Fund

Gemma Frisius Fund

Venture capital · Leuven, Belgium · Europe

kuleuven.be

Gemma Frisius Fund is a seed capital fund established in 1997 as a joint venture between KU Leuven, KBC Bank and BNP Paribas Fortis Private Equity Belgium. It provides seed capital to KU Leuven spin-off companies and supports their creation and growth.

Invests inHealthcare & Biotech

In its own wordsuniversity spin-offsseed capitaltechnology transferresearch commercializationstudent entrepreneurship

Your fit with Gemma Frisius Fund

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
3portfolio companies
3funding rounds on record
1rounds, last 12 months
$5M to $20Mtypical round it comes in at
Series Amost frequent entry

Gemma Frisius Fund lists 3 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series A, 67% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in Belgium. It invests most often alongside PMV, AdBio partners and Asabys Partners.

Counts come from funding rounds that name Gemma Frisius Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed0%
Seed33%
Series A67%
Series B0%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2520
'2610

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
PMV2
AdBio partners1
Asabys Partners1
Capricorn Partners1
Jeito Capital1
Newton Biocapital1
V-Bio Ventures1

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers3100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Co-investor network

who it backs companies with, and who they back together
6 shared companies4 shared companies3 shared companies2 shared companies2 shared companies2 shared companies2 shared companiesPMV: 2 shared companiesPMV2AdBio partners: 1 shared companiesAdBio partners1Asabys Partners: 1 shared companiesAsabys Partners1Capricorn Partners: 1 shared companiesCapricorn Partners1Jeito Capital: 1 shared companiesJeito Capital1Newton Biocapital: 1 shared companiesNewton Biocapital1V-Bio Ventures: 1 shared companiesV-Bio Ventures1
Shared portfolio companies with Gemma Frisius FundFirms that also back companies together

All co-investors or Compare portfolios with PMV

Compare Gemma Frisius Fund head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Recent portfolio activity

when companies last raised with Gemma Frisius Fund
DateCompanyStage
4 Feb 2026Runeasiruneasi.aiSeed
9 Sept 2025aspect-analytics.comaspect-analytics.comSeries A
24 Mar 2025Augustine Therapeuticsaugustinetx.comSeries A

Round details for Gemma Frisius Fund

Amounts, full round histories and every co-investor in Gemma Frisius Fund's rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

3 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
aspect-analytics.comaspect-analytics.com · BelgiumAspect Analytics provides software for analyzing spatial biology data to drive drug discovery and development.
Healthcare & Biotech
Sept 2025Series AFunding round
Augustine Therapeuticsaugustinetx.com · BelgiumAugustine Therapeutics develops novel HDAC6 inhibitors for the treatment of chronic diseases
Healthcare & Biotech
Mar 2025Series AFunding round
Runeasiruneasi.ai · BelgiumRuneasi provides a running gait and jump analysis tool for physios to assess runners
Healthcare & Biotech
Feb 2026SeedFunding round

About this data

site last read 8 Nov 2026
The homepage of Gemma Frisius Fund, as last read
kuleuven.be as VCinfo last read it
Site
kuleuven.be
Last read
8 Nov 2026
Watching since
6 Nov 2026
Rounds since
24 Mar 2025
Companies checked
3

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Gemma Frisius Fund's profile as data

Pull Gemma Frisius Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/kuleuven.be

# also
GET /v1/firms/kuleuven.be/portfolio
GET /v1/firms/kuleuven.be/coinvestors
GET /v1/firms/kuleuven.be/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing